Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6GES

Crystal structure of ERK1 covalently bound to SM1-71

6GES の概要
エントリーDOI10.2210/pdb6ges/pdb
関連するPDBエントリー6G54
分子名称Mitogen-activated protein kinase 3, N-{2-[(5-chloro-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}propanamide, ~{N}-[2-[[5-chloranyl-2-[[4-(4-methylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide, ... (6 entities in total)
機能のキーワードkinase, covalent inhibitor, mapk, structural genomics, structural genomics consortium, sgc, transferase
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数2
化学式量合計88453.52
構造登録者
Chaikuad, A.,Suman, R.,Arrowsmith, C.H.,Edwards, A.M.,Bountra, C.,Gray, N.S.,Knapp, S.,Structural Genomics Consortium (SGC) (登録日: 2018-04-27, 公開日: 2019-02-27, 最終更新日: 2024-01-17)
主引用文献Rao, S.,Gurbani, D.,Du, G.,Everley, R.A.,Browne, C.M.,Chaikuad, A.,Tan, L.,Schroder, M.,Gondi, S.,Ficarro, S.B.,Sim, T.,Kim, N.D.,Berberich, M.J.,Knapp, S.,Marto, J.A.,Westover, K.D.,Sorger, P.K.,Gray, N.S.
Leveraging Compound Promiscuity to Identify Targetable Cysteines within the Kinome.
Cell Chem Biol, 26:818-, 2019
Cited by
PubMed Abstract: Covalent kinase inhibitors, which typically target cysteine residues, represent an important class of clinically relevant compounds. Approximately 215 kinases are known to have potentially targetable cysteines distributed across 18 spatially distinct locations proximal to the ATP-binding pocket. However, only 40 kinases have been covalently targeted, with certain cysteine sites being the primary focus. To address this disparity, we have developed a strategy that combines the use of a multi-targeted acrylamide-modified inhibitor, SM1-71, with a suite of complementary chemoproteomic and cellular approaches to identify additional targetable cysteines. Using this single multi-targeted compound, we successfully identified 23 kinases that are amenable to covalent inhibition including MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3, SRC, YES1, FGFR1, ZAK (MLTK), MAP3K1, LIMK1, and RSK2. The identification of nine of these kinases previously not targeted by a covalent inhibitor increases the number of targetable kinases and highlights opportunities for covalent kinase inhibitor development.
PubMed: 30982749
DOI: 10.1016/j.chembiol.2019.02.021
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.07 Å)
構造検証レポート
Validation report summary of 6ges
検証レポート(詳細版)ダウンロードをダウンロード

226707

件を2024-10-30に公開中

PDB statisticsPDBj update infoContact PDBjnumon